School of Medicine


Showing 11-20 of 134 Results

  • Mishu Chandra

    Mishu Chandra

    Clinical Assistant Professor, Adult Neurology

    BioDr. Chandra is clinical assistant professor in the divisions of Comprehensive Neurology and Epilepsy in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine. She is board-certified in Neurology, Clinical Neurophysiology, and Epilepsy.

    A Bay Area native, Dr. Chandra completed her undergraduate education at the University of California, Berkeley. She earned her medical degree from Rush University Medical College and completed her neurology residency at the University of Texas Southwestern Medical Center (UTSW), where she served as the Academic Chief Resident. She pursued her passion for medical education by founding the Clinician Educator Track for the residency program, and continued to serve as Course Director during her fellowship training in both Clinical Neurophysiology and Epilepsy at UTSW. Dr. Chandra later served as an Associate Program Director for the Neurology residency program. Her clinical and research interests include psychiatric disorders in refractory epilepsy, perioperative management of refractory epilepsy requiring surgical intervention, women’s health in neurology, as well as medical education in clinical neurophysiology.

  • Felix Chang, MD

    Felix Chang, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Felix Chang's clinical practice mainly involves intraoperative neurophysiologic monitoring (IONM) and the treatment of neurological disorders with botulinum toxin. He earned his medical degree at the University of Texas Southwestern Medical Center. He completed his neurology residency at the Harvard Neurology Program at the Beth Israel Deaconess Medical Center in Boston. He then went on to complete a fellowship in clinical neurophysiology with a focus in intraoperative neurophysiologic monitoring at Stanford.

  • Gaurav Mohit Chattree

    Gaurav Mohit Chattree

    Instructor, Adult Neurology

    BioDr. Chattree is a board-certified neurologist with the Stanford Movement Disorders Center and an Instructor in the Department of Neurology and Neurological Sciences. He provides comprehensive care for patients with movement disorders, which includes deep brain stimulation evaluation/programming and botulinum toxin injections. In addition to his clinical practice, Dr. Chattree conducts research in the lab of Dr. Mark Schnitzer at Stanford, where he uses optical and genetic techniques in mice to develop new treatments for movement disorders.

  • S. Charles Cho, MD

    S. Charles Cho, MD

    Clinical Professor, Adult Neurology
    Clinical Professor (By courtesy), Neurosurgery

    Current Research and Scholarly InterestsClinical research focused on peripheral nerve and muscle disorders. Also involved with prevention of cerebrovascular disesase in the intraoperative setting. Ongoing clincial studies include treatments for Amyotrophic Lateral Sclerosis (ALS), Inflammatory Demyelinating Neuropathy and HIV neuropathic pain.

  • John W. Day, MD, PhD

    John W. Day, MD, PhD

    Professor of Neurology and Neurological Sciences (Adult Neurology), of Pediatrics (Genetics) and, by courtesy, of Pathology

    Current Research and Scholarly InterestsOur Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.

  • Leana Doherty, MD

    Leana Doherty, MD

    Clinical Associate Professor, Adult Neurology

    BioDr. Doherty is a board-certified, fellowship-trained neurologist with Stanford Health Care. She is also a clinical associate professor in the Department of Neurology & Neurological Sciences at Stanford University School of Medicine.

    Dr. Doherty specializes in Guillain-Barre syndrome, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and other neuroinflammatory, neuromuscular, and general neurologic conditions.

    Her research interests include the diagnosis and management of neuromuscular disorders, and quality improvement for inpatient neurologic treatment and management. She has won numerous awards for her research, clinical, and teaching expertise in neurology.

    Dr. Doherty has published in several peer-reviewed journals including Neurology, Neuromuscular Disorders, and Neurology: Neuroimmunology & Neuroinflammation. She has delivered presentations around the country and lectured before an international audience of neurology residents. Dr. Doherty serves as co-associate editor of Annals of Clinical and Translational Neurology (interACTN) and associate editor of New England Journal of Medicine (NEJM) Journal Watch Neurology. She is on the editorial board of The Neurohospitalist.

    Dr. Doherty is a member of the American Academy of Neurology, American Neurological Association, Neurohospitalist Society, and Peripheral Nerve Society.

  • Les Dorfman, MD

    Les Dorfman, MD

    Professor of Neurology and Neurological Sciences, Emeritus

    Current Research and Scholarly InterestsClinical electrophysiology of the peripheral and central nervous systems, including nerve conduction velocity; electromyography (EMG); and visual, auditory and somatosensory evoked potentials. Multiple sclerosis (MS) diagnosis and treatment. Neurological education.

  • Rachelle Dugue, MD, PhD

    Rachelle Dugue, MD, PhD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Dugue is a board-certified neurologist within the Neurohospitalist Division. She cares for patients at both Stanford Health Care and Stanford Health Care Tri-Valley. She received her MD and PhD at SUNY Downstate Medical Center, where she completed a thesis studying novel treatments for traumatic brain injury. Dr. Dugue then completed her neurology residency at Columbia University Medical Center-New York Presbyterian, followed by a vascular neurology fellowship at Stanford University Hospital.

    Dr. Dugue provides comprehensive, individualized care for patients with a wide range of neurological conditions. She has been recognized for her dedication to excellence in patient care, medical education, and student mentorship.

    Her research interests are centered on acute neurologic care, clinical trials, stroke, and neuroinfectious disease. Dr. Dugue has published in multiple peer-reviewed journals, including The Neurohospitalist, Practical Neurology, Annals of Clinical and Translational Neurology, and Neurology.

  • Shefali Dujari, MD

    Shefali Dujari, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Dujari is a board-certified neurologist and fellowship-trained neurohospitalist, specializing in the care of acute neurologic disorders. She practices at both Stanford Hospital and Stanford ValleyCare. She completed her medical training at Boston University, internal medicine preliminary year at California Pacific Medical Center, neurology residency at Stanford University, and neurohospitalist fellowship at Stanford University. She serves as the associate program director of the Stanford Adult Neurology Residency program, the Neurosciences Quality Director at ValleyCare, and the Neurology Resident & Fellow Wellness & Mentoring Committee faculty lead. She has a special interest in medical education and quality improvement.

  • Jeffrey Dunn, MD

    Jeffrey Dunn, MD

    Clinical Professor, Adult Neurology

    Current Research and Scholarly InterestsTranslational research in the human application of emerging immunotherapies for neurological disease, focusing on Multiple Sclerosis, CIS, transverse myelitis and Neuromyelitis Optica (NMO). Collaborative research with Stanford and extramural scientific faculty to identify biomarkers of disease activity and treatment response in humans. Clinical trials to assess efficacy of emerging treatments for MS, CIS and NMO.